FDA Forms Pediatric Ethics Subcommittee
This article was originally published in The Pink Sheet Daily
Executive Summary
The advisory panel will address pediatric ethical issues and IRB referrals related to clinical investigations involving children. The subcommittee's preliminary recommendations will be presented to the new Pediatric Advisory Committee.
You may also be interested in...
Dextroamphetamine Study Including Healthy Children Will Be First Test For Pediatric Ethics Subcommittee
NIH study proposes single-dose administration to both children with attention deficit/hyperactivity disorder and healthy volunteers. Institutional Review Board requested special review from HHS after two divided votes.
Dextroamphetamine Study Including Healthy Children Will Be First Test For Pediatric Ethics Subcommittee
NIH study proposes single-dose administration to both children with attention deficit/hyperactivity disorder and healthy volunteers. Institutional Review Board requested special review from HHS after two divided votes.
SSRIs And Suicide To Be Discussed By Pediatric Advisory Cmte. In September
Joint session with Psychopharmacologic Advisory Committee will be new cross-center committee's first meeting.